相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association
Michael Miller et al.
CIRCULATION (2011)
ESC/EAS GUIDELINES ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2011)
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M. John Chapman et al.
EUROPEAN HEART JOURNAL (2011)
Association between extended-release niacin treatment and glycemic control in patients with type 2 diabetes mellitus: analysis of an administrative-claims database
Baishali M. Ambegaonkar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
EUROPEAN HEART JOURNAL (2011)
Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I
Estelle Nobecourt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Effects of High-Density Lipoproteins on Pancreatic β-Cell Insulin Secretion
Michelle A. Fryirs et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
Eric Bruckert et al.
ATHEROSCLEROSIS (2010)
Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx
R. Datar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
HDL and LDL cholesterol significantly influence β-cell function in type 2 diabetes mellitus
Janine K. Kruit et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Philip Greenland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial
Paul M. Ridker et al.
LANCET (2010)
Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy
Subha L. Airan-Javia et al.
AMERICAN HEART JOURNAL (2009)
Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease
Dorbie Maccubbin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Acetylsalicylic Acid Reduces Niacin Extended-Release-Induced Flushing in Patients with Dyslipidemia
Roopal B. Thakkar et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2009)
Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells
Shobha H. Ganji et al.
ATHEROSCLEROSIS (2009)
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations
Jacques Genest et al.
CANADIAN JOURNAL OF CARDIOLOGY (2009)
Future Role for Selective Phospholipase A2 Inhibitors in the Prevention of Atherosclerotic Cardiovascular Disease
Robert S. Rosenson
CARDIOVASCULAR DRUGS AND THERAPY (2009)
High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
Brian G. Drew et al.
CIRCULATION (2009)
Nicotinic acid: A new look at an old drug
John A. Farmer
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Nicotinic acid and the prevention of coronary artery disease
Janet E. Digby et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function A Randomized, Placebo-Controlled, Magnetic Resonance Imaging Study
Justin M. S. Lee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness
Allen J. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The safety of niacin in the US Food and Drug Administration Adverse Event Reporting database
Alawi A. Alsheikh-Ali et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Nicotinic acid: Pharmacological effects and mechanisms of action
Andreas Gille et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and apoB-containing lipoproteins
Stefania Lamon-Fava et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice
Jose W. A. van der Hoorn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Nicotinic acid: an old drug with a promising future
E. T. Bodor et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Nicotinic acid: recent developments
Vaijinath S. Kamanna et al.
CURRENT OPINION IN CARDIOLOGY (2008)
Niacin inhibits surface expression of ATP synthase beta chain in HepG2 cells: implications for raising HDL
Lin-Hua Zhang et al.
JOURNAL OF LIPID RESEARCH (2008)
Effects of niacin on glucose control in patients with dyslipidemia
Ronald B. Goldberg et al.
MAYO CLINIC PROCEEDINGS (2008)
The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome
M. Thoenes et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Extended-release niacin raises adiponectin and leptin
Sabine Westphal et al.
ATHEROSCLEROSIS (2007)
Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients
Gregory A. Nichols et al.
CLINICAL THERAPEUTICS (2007)
Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties
A. Hoang et al.
DIABETOLOGIA (2007)
Niacin in cardiovascular prevention: mechanisms, efficacy, and safety
John R. Guyton
CURRENT OPINION IN LIPIDOLOGY (2007)
Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients
R. S. Birjmohun et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Safety considerations with niacin therapy
John R. Guyton et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Niacin affects cell adhesion molecules and plasminogen activator inhibitor-1 in HepG2 cells
S. Tavintharan et al.
CLINICA CHIMICA ACTA (2007)
Genetic factors affecting HDL levels, structure, metabolism and function
Dmitri Sviridov et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells
Zoltan Benyo et al.
MOLECULAR PHARMACOLOGY (2006)
The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3
Allen J. Taylor et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease
Jeffrey T. Kuvin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans
K Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatment
H. Oberwittler et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
Anatol Kontush et al.
PHARMACOLOGICAL REVIEWS (2006)
Prevalence and control of dyslipidemia among persons with diabetes in the United States
MJ Jacobs et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study
E Bruckert et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial
BF Asztalos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review
LA Carlson
JOURNAL OF INTERNAL MEDICINE (2005)
Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds - A meta-analysis of randomized controlled trials
RS Birjmohun et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: Effects on progression of coronary heart disease and clinical events
EJ Whitney et al.
ANNALS OF INTERNAL MEDICINE (2005)
New perspectives on the use of niacin in the treatment of lipid disorders
J McKenney
ARCHIVES OF INTERNAL MEDICINE (2004)
Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)
XQ Zhao et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin
T Rubic et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells
SH Ganji et al.
JOURNAL OF LIPID RESEARCH (2004)
Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2 - A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins
AJ Taylor et al.
CIRCULATION (2004)
High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study
BF Asztalos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Inhibition of human P450 enzymes by nicotinic acid and nicotinamide
C Gaudineau et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia
CD Meyers et al.
ANNALS OF INTERNAL MEDICINE (2003)
Molecular identification of nicotinic acid receptor
T Soga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Molecular identification of high and low affinity receptors for nicotinic acid
A Wise et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
S Tunaru et al.
NATURE MEDICINE (2003)
Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects
KJ Cooper et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Antiatherothrombotic effects of nicotinic acid
RS Rosenson
ATHEROSCLEROSIS (2003)
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes - Results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial
SM Grundy et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
BG Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages
N Ouchi et al.
CIRCULATION (2001)
Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease - The ADMIT Study: A randomized trial
MB Elam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia
A Goldberg et al.
AMERICAN JOURNAL OF CARDIOLOGY (2000)
分享论文
